Bayesian Capital Management, LP Petmed Express Inc Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$29.0 - $41.83 $177,480 - $255,999	-6,120 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.94 - $40.96 $114,554 - $167,936	-4,100 Reduced 40.12%	6,120 $218,000
Q1 2020 May 15, 2020	BUY	$22.18 - $28.78 $15,326 - $19,886	691 Added 7.25%	10,220 $294,000
Q4 2019 Feb 14, 2020	BUY	$17.87 - $27.37 $170,283 - $260,808	9,529 New	9,529 $224,000
Q1 2018 May 15, 2018	SELL	$41.2 - $53.24 $353,825 - $457,225	-8,588 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$34.19 - $48.11 $198,302 - $279,038	-5,800 Reduced 40.31%	8,588 $391,000
Q3 2017 Nov 14, 2017	BUY	$33.15 - $48.95 $476,962 - $704,292	14,388	14,388 $477,000

9.38M

184K

980K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $89.3M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.